Articore Group Limited (ASX:ATG) Reaffirms FY25 Guidance and Announces Strategic Review
Articore Group Limited (ASX:ATG) reaffirms its FY25 guidance and initiates a strategic review to enhance shareholder value and accelerate growth.
Category: Companies
Cokal Limited (ASX:CKA) Secures US$15 Million Debt Funding
Cokal Limited (ASX:CKA) secures US$15 million in strategic debt funding to boost metallurgical coal production and ends agreements with Cratus.
GenusPlus Group Ltd (ASX:GNP) Secures $130 Million NBN Contract
GenusPlus Group Ltd (ASX:GNP) secures a $130 million contract with NBN Co to upgrade fiber infrastructure across Western Australia.
PYC Therapeutics (ASX:PYC) Receives Approval for Dose Escalation in ADOA Clinical Trial
PYC Therapeutics (ASX:PYC) receives approval to escalate dosing in its ADOA clinical trial, advancing development of its PYC-001 drug candidate.
4DMedical Limited (ASX:4DX) Partners with Olympus to Launch SeleCT™ Screening Campaign
4DMedical Limited (ASX:4DX) partners with Olympus to deploy AI-powered SeleCT™ Screening, enhancing COPD diagnosis and treatment.
Siren Gold Limited (ASX:SNG) Announces High-Grade Antimony-Gold Update at Langdons
Siren Gold Limited (ASX:SNG) reports significant gold and antimony grades from its Langdons project, highlighting exploration progress and next steps.
Radiopharm Theranostics (ASX:RAD) Receives FDA Fast Track for RAD101
Radiopharm Theranostics (ASX:RAD) secures FDA Fast Track for RAD101, advancing its Phase 2 trial in brain metastases imaging.
Fletcher Building Limited (ASX:FBU) Receives Inquiries Amid Strategic Review
Fletcher Building (ASX:FBU) receives inquiries following strategic review, with further details to be disclosed at Investor Day.
Finbar Group Limited (ASX:FRI) Announces Early Appointment of Ronald Chan as CEO
Finbar Group Limited (ASX:FRI) appoints Ronald Chan as CEO ahead of schedule, emphasizing leadership stability and future growth.
Zip Co Limited (ASX:ZIP) Upgrades FY25 Guidance Amid Strong May Performance
Zip Co Limited (ASX:ZIP) upgrades FY25 guidance to $160m cash EBTDA, citing strong May performance and US TTV growth above 40%.